As of 2025-10-16, the Relative Valuation of FibroGen Inc (FGEN) is (6.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.04 USD, the upside of FibroGen Inc based on Relative Valuation is -163.2%.
The range of the Relative Valuation is (5.60) - (8.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 15.8x | 13.7x |
| Forward P/E multiples | 10.9x - 17.3x | 13.6x |
| Fair Price | (5.60) - (8.08) | (6.98) |
| Upside | -150.8% - -173.2% | -163.2% |
| Date | P/E |
| 2025-10-15 | -21.59 |
| 2025-10-14 | -21.65 |
| 2025-10-13 | -21.45 |
| 2025-10-10 | -20.63 |
| 2025-10-09 | -21.43 |
| 2025-10-08 | -22.29 |
| 2025-10-07 | -21.65 |
| 2025-10-06 | -22.12 |
| 2025-10-03 | -22.94 |
| 2025-10-02 | -23.33 |
| 2025-10-01 | -23.51 |
| 2025-09-30 | -23.95 |
| 2025-09-29 | -24.08 |
| 2025-09-26 | -24.07 |
| 2025-09-25 | -23.94 |
| 2025-09-24 | -24.21 |
| 2025-09-23 | -23.41 |
| 2025-09-22 | -23.92 |
| 2025-09-19 | -22.12 |
| 2025-09-18 | -22.25 |
| 2025-09-17 | -21.78 |
| 2025-09-16 | -22.51 |
| 2025-09-15 | -23.15 |
| 2025-09-12 | -23.52 |
| 2025-09-11 | -24.31 |
| 2025-09-10 | -22.51 |
| 2025-09-09 | -22.45 |
| 2025-09-08 | -21.82 |
| 2025-09-05 | -23.66 |
| 2025-09-04 | -22.12 |
| 2025-09-03 | -23.39 |
| 2025-09-02 | -23.82 |
| 2025-08-29 | -23.13 |
| 2025-08-28 | -21.76 |
| 2025-08-27 | -20.49 |
| 2025-08-26 | -20.24 |
| 2025-08-25 | -20.79 |
| 2025-08-22 | -21.86 |
| 2025-08-21 | -21.69 |
| 2025-08-20 | -20.77 |
| 2025-08-19 | -20.65 |
| 2025-08-18 | -22.10 |
| 2025-08-15 | -18.57 |
| 2025-08-14 | -18.54 |
| 2025-08-13 | -19.32 |
| 2025-08-12 | -18.09 |
| 2025-08-11 | -16.37 |
| 2025-08-08 | -17.03 |
| 2025-08-07 | -15.53 |
| 2025-08-06 | -13.89 |